The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
Open Access
- 22 March 2023
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 18 (1) , 1-12
Abstract
The aim: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). Methods: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0". Results: We discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development. Conclusions: SIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating diseaseActa Neuropathologica Communications, 2014
- Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brainNature Cell Biology, 2013
- Resveratrol Neuroprotection in a Chronic Mouse Model of Multiple SclerosisFrontiers in Neurology, 2012
- SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cellsFrontiers in Cellular Neuroscience, 2012
- Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathwayNature Medicine, 2011
- Optic Neuritis and Retinal Ganglion Cell Loss in a Chronic Murine Model of Multiple SclerosisFrontiers in Neurology, 2011
- Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple SclerosisJournal of Neuro-Ophthalmology, 2010
- Multiple Sclerosis Risk After Optic NeuritisArchives of Neurology, 2008
- SIRT1 Activation Confers Neuroprotection in Experimental Optic NeuritisInvestigative Ophthalmology & Visual Science, 2007
- SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosisThe EMBO Journal, 2007